Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in DFTX — Definium Therapeutics, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in DFTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,926,476
+$386,958 QoQ
Shares Held
40,954
-49.7% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#143
of 358 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DFTX Over Time

Shares Held

Position Value (USD)

Derivatives in DFTX

reported options exposure · as of Jun 30, 2026
CallValue
$65,216,256
CallShares
1,386,400
PutValue
$22,155,840
PutShares
471,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,650,012,247 across 349 Biotechnology names. DFTX ranks #86 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DFTX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,926,476 40,954
2026-06-30 $22,155,840 471,000
2026-06-30 $65,216,256 1,386,400
2026-03-31 $4,086,180 216,200
2026-03-31 $15,876,000 840,000
2026-03-31 $1,539,518 81,456